DH Valuation

Definitive Healthcare Corp

Add to Watchlist

Advanced Chart

3.930

+0.05(1.289%)1D

Overview
Forecast
Valuation
Earnings

DH Relative Valuation

DH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DH is overvalued; if below, it's undervalued.

Historical Valuation

Definitive Healthcare Corp (DH) is now in the Fair zone, suggesting that its current forward PE ratio of 16.50 is considered Fairly compared with the five-year average of 53.64. The fair price of Definitive Healthcare Corp (DH) is between 2.12 to 21.23 according to relative valuation methord.

Relative Value

Fair Zone

2.12-21.23

Current Price：3.92

Fair

16.67

Trailing

Forward

7.80

EV/EBITDA

Definitive Healthcare Corp. (DH) has a current EV/EBITDA of 7.80. The 5-year average EV/EBITDA is 24.46. The thresholds are as follows: Strongly Undervalued below -9.11, Undervalued between -9.11 and 7.67, Fairly Valued between 41.24 and 7.67, Overvalued between 41.24 and 58.03, and Strongly Overvalued above 58.03. The current Forward EV/EBITDA of 7.80 falls within the Historic Trend Line -Fairly Valued range.

9.53

EV/EBIT

Definitive Healthcare Corp. (DH) has a current EV/EBIT of 9.53. The 5-year average EV/EBIT is 26.41. The thresholds are as follows: Strongly Undervalued below -10.13, Undervalued between -10.13 and 8.14, Fairly Valued between 44.68 and 8.14, Overvalued between 44.68 and 62.95, and Strongly Overvalued above 62.95. The current Forward EV/EBIT of 9.53 falls within the Historic Trend Line -Fairly Valued range.

1.74

Definitive Healthcare Corp. (DH) has a current PS of 1.74. The 5-year average PS is 5.56. The thresholds are as follows: Strongly Undervalued below -3.10, Undervalued between -3.10 and 1.23, Fairly Valued between 9.90 and 1.23, Overvalued between 9.90 and 14.23, and Strongly Overvalued above 14.23. The current Forward PS of 1.74 falls within the Historic Trend Line -Fairly Valued range.

9.28

P/OCF

Definitive Healthcare Corp. (DH) has a current P/OCF of 9.28. The 5-year average P/OCF is 22.73. The thresholds are as follows: Strongly Undervalued below -11.10, Undervalued between -11.10 and 5.81, Fairly Valued between 39.65 and 5.81, Overvalued between 39.65 and 56.56, and Strongly Overvalued above 56.56. The current Forward P/OCF of 9.28 falls within the Historic Trend Line -Fairly Valued range.

8.77

P/FCF

Definitive Healthcare Corp. (DH) has a current P/FCF of 8.77. The 5-year average P/FCF is 23.79. The thresholds are as follows: Strongly Undervalued below -10.36, Undervalued between -10.36 and 6.71, Fairly Valued between 40.87 and 6.71, Overvalued between 40.87 and 57.95, and Strongly Overvalued above 57.95. The current Forward P/FCF of 8.77 falls within the Historic Trend Line -Fairly Valued range.

Definitive Healthcare Corp (DH) has a current Price-to-Book (P/B) ratio of 1.30. Compared to its 3-year average P/B ratio of 1.15 , the current P/B ratio is approximately 13.33% higher. Relative to its 5-year average P/B ratio of 1.63, the current P/B ratio is about -19.88% higher. Definitive Healthcare Corp (DH) has a Forward Free Cash Flow (FCF) yield of approximately 11.93%. Compared to its 3-year average FCF yield of 5.80%, the current FCF yield is approximately 105.67% lower. Relative to its 5-year average FCF yield of 4.66% , the current FCF yield is about 156.05% lower.

1.32

P/B

Median3y

1.15

Median5y

1.63

11.62

FCF Yield

Median3y

5.80

Median5y

4.66

Competitors Valuation Multiple

The average P/S ratio for DH's competitors is 2.18, providing a benchmark for relative valuation. Definitive Healthcare Corp Corp (DH) exhibits a P/S ratio of 1.74, which is -20.23% above the industry average. Given its robust revenue growth of -6.76%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

DH.O

Definitive Healthcare Corp

Priority Technology Holdings Inc

Weave Communications Inc

Performance Decomposition

Market capitalization of DH decreased by 16.20% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -20.03 to -262.02.

The secondary factor is the Revenue Growth, contributed -6.76%to the performance.

Overall, the performance of DH in the past 1 year is driven by Margin Expansion. Which is more sustainable.

-6.76%

63.48M → 59.19M

Revenue Growth

1208.14%

-20.03 → -262.02

Margin Expansion

-1217.58%

0.08 → -0.88

P/E Change

-16.20%